SE396693B - Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan - Google Patents

Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan

Info

Publication number
SE396693B
SE396693B SE7001975A SE197570A SE396693B SE 396693 B SE396693 B SE 396693B SE 7001975 A SE7001975 A SE 7001975A SE 197570 A SE197570 A SE 197570A SE 396693 B SE396693 B SE 396693B
Authority
SE
Sweden
Prior art keywords
corticotropine
enhanced
synthetic
extended effect
preparing complex
Prior art date
Application number
SE7001975A
Other languages
English (en)
Inventor
Sok
Original Assignee
Paulsen Fredrik
Paulsen Eva Wolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paulsen Fredrik, Paulsen Eva Wolf filed Critical Paulsen Fredrik
Priority to SE7001975A priority Critical patent/SE396693B/sv
Priority to DE19712107282 priority patent/DE2107282A1/de
Priority to NL7102023A priority patent/NL7102023A/xx
Priority to GB2196571A priority patent/GB1345573A/en
Publication of SE396693B publication Critical patent/SE396693B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
SE7001975A 1970-02-16 1970-02-16 Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan SE396693B (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE7001975A SE396693B (sv) 1970-02-16 1970-02-16 Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
DE19712107282 DE2107282A1 (de) 1970-02-16 1971-02-16 Verfahren zur Verstärkung und Ver langerung der Wirkung von synthetischem Corticotropin und von seinen Segmentden vaten
NL7102023A NL7102023A (sv) 1970-02-16 1971-02-16
GB2196571A GB1345573A (en) 1970-02-16 1971-04-19 Process for preparing a synthetic corticotropin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7001975A SE396693B (sv) 1970-02-16 1970-02-16 Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan

Publications (1)

Publication Number Publication Date
SE396693B true SE396693B (sv) 1977-10-03

Family

ID=20259175

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7001975A SE396693B (sv) 1970-02-16 1970-02-16 Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan

Country Status (4)

Country Link
DE (1) DE2107282A1 (sv)
GB (1) GB1345573A (sv)
NL (1) NL7102023A (sv)
SE (1) SE396693B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758578A1 (de) * 1977-12-29 1979-07-05 Hoechst Ag Stabile sekretinzubereitung, verfahren zu ihrer herstellung und ihre verwendung
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
DE4224749A1 (de) * 1992-07-27 1994-02-03 Adelmann Ag Verfahren zur Beseitigung von in Kunststoff gebundenen Treibmittelgasen sowie Anlage zur Durchführung des Verfahrens

Also Published As

Publication number Publication date
GB1345573A (en) 1974-01-30
DE2107282A1 (de) 1971-09-02
NL7102023A (sv) 1971-08-18

Similar Documents

Publication Publication Date Title
TR19550A (tr) Poliueretan koepuek plastiklerinin istihsaline mahsus usul
FI54926B (fi) Vattenabsorberande alkalimetallkarboxylatsalter av staerkelsepolyakrylonitrilympkopolymer och foerfarande foer deras framstaellning
FI54741C (fi) Elektrisk kokapparat med aotminstone en kokplatta och foerfarande foer tillverkning av en saodan kokapparat
SE417205B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
FI56686B (fi) Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotis verkan
BE823743Q (fr) Formation de carbures de tungstene et de molydene
SE387115B (sv) Sett att framstella nitro-imidazoler med antimikrobiell verkan
FI54316C (fi) Foerfarande foer framstaellning av adenosin-5'-karbonsyraderivat med kretsomloppsverkan
SE373578B (sv) Sett att framstella steroidooxazolidiner och steroido-oxazolidino-oxaziner
FI56100B (fi) Loesningskoncentrat med fungicid och acaricid verkan
SE398119B (sv) Forfarande for framstellning av legre-alkylfuran-3-tiol och legre-alkyldihydrofuran-3-tiol till anvendning sasom aromatiseringsmedel
SE380802B (sv) 3-morfolino-2-cyancakrylamidforeningar och sett att framstella desamma
SE380277B (sv) Sett att framstella fenolhartsskum av fenolresolharts och oxalkylerade fenoler
FI56191C (fi) Foerfarande foer polymerisering av etylen och vid foerfarandet anvaent katalysatorsystem
SE385981B (sv) Sett att indikera nervaron av vanadin i en jordformation
SE396693B (sv) Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
SE393982B (sv) Sett att framstella dihydrokinolinderivat med antioxiderande verkan
BE769922R (fr) Polymercapto-polyphosphites et polyphosphates
SE403287B (sv) Sett att framstella 1-etyl-imidazoler med antimykotisk verkan
FI54620C (fi) Flerstegsfoerfarande foer blekning av cellulosa med en klorfoerening och peraettiksyra
SE396603B (sv) Fenazinderivat med vextfungicid verkan
SE381456B (sv) Sett att framstella substituerade 5-cyklohexyl-indankarbonsyror och derivat av dessa
SE396749B (sv) Fenazinderivat med vextfungicid verkan
FI55639C (fi) Foerfarande foer framstaellning av en med tillsatsaemnen saerskilt eldskyddsmedel belagd fiberprodukt
SE383889B (sv) Forfarande for framstellning av cefalexin och hetacefalexin